A Bayer AG (BAYN) unit will pay $15 million to settle a U.S. lawsuit claiming it illegally marketed aspirin mixed with supplements. The settlement between the unit, Bayer Healthcare LLC, and U.S. consumers received preliminary approval today from a federal judge in Brooklyn, New York. “Clearly, this was a hard-fought case,” Judge Brian M. Cogan said at a hearing. “The settlement negotiations were extensive. Significant compromises were made by both sides.” Bayer Healthcare was sued by consumers in 2008 over its Bayer Women’s Low Dose Aspirin + Calcium and Bayer Aspirin with Heart Advantage, containing the supplement phytosterols.
